AskBio has dosed the first participant in the second group of a Phase 1/2 trial of AB-1003, an experimental gene therapy for ...

Strasbourg (France), March 11, 2025, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today ...

Introduction Illustrator is widely regarded as the gold standard for vector graphic design. Whether you’re a seasoned ...

Atsign's NoPorts technology addresses these vulnerabilities by making APIs invisible. By eliminating the need for open listening ports on the device hosting the API, NoPorts effectively removes the ...